AAAAAA

   
Results: 1-10 |
Results: 10
EFFECT OF BONE PROTEINS ON HUMAN PROSTATE-CANCER CELL-LINES IN-VITRO
Authors: HULLINGER TG MCCAULEY LK DEJOODE ML SOMERMAN MJ
Citation: Tg. Hullinger et al., EFFECT OF BONE PROTEINS ON HUMAN PROSTATE-CANCER CELL-LINES IN-VITRO, The Prostate, 36(1), 1998, pp. 14-22
THE ROLE OF BONE-MATRIX IN PROSTATE-CANCER METASTASIS
Authors: HULLINGER TG DEJOODE ML MCCAULEY LK SOMERMAN MJ
Citation: Tg. Hullinger et al., THE ROLE OF BONE-MATRIX IN PROSTATE-CANCER METASTASIS, Journal of bone and mineral research, 12, 1997, pp. 691-691
TEMPORAL EXPRESSION OF C-FOS MESSENGER-RNA FOLLOWING BALLOON INJURY IN THE RAT COMMON CAROTID-ARTERY
Authors: MILLS CJ NORTHRUP JL HULLINGER TG SIMMONS CA SHEBUSKI RJ JONES DA
Citation: Cj. Mills et al., TEMPORAL EXPRESSION OF C-FOS MESSENGER-RNA FOLLOWING BALLOON INJURY IN THE RAT COMMON CAROTID-ARTERY, Cardiovascular Research, 32(5), 1996, pp. 954-961
THE EFFECT OF P-SELECTIN BLOCKADE ON NEOINTIMAL LESION DEVELOPMENT INA PRIMATE CAROTID INJURY MODEL
Authors: HULLINGER TG DEGRAAF GL HARTMAN JC SHEBUSKI RJ
Citation: Tg. Hullinger et al., THE EFFECT OF P-SELECTIN BLOCKADE ON NEOINTIMAL LESION DEVELOPMENT INA PRIMATE CAROTID INJURY MODEL, The FASEB journal, 9(4), 1995, pp. 845-845
P-SELECTIN ANTAGONISM WITH THE MONOCLONAL-ANTIBODY, CY1747, PREVENTS VENOUS THROMBOSIS IN-VIVO
Authors: JAIN KM HULLINGER TG HUMPHREY WR SHEBUSKI RJ
Citation: Km. Jain et al., P-SELECTIN ANTAGONISM WITH THE MONOCLONAL-ANTIBODY, CY1747, PREVENTS VENOUS THROMBOSIS IN-VIVO, Circulation, 92(8), 1995, pp. 2326-2326
IN-VIVO VALIDATION OF A TRANSIT-TIME ULTRASONIC VOLUME FLOW METER
Authors: HARTMAN JC OLSZANSKI DA HULLINGER TG BRUNDEN MN
Citation: Jc. Hartman et al., IN-VIVO VALIDATION OF A TRANSIT-TIME ULTRASONIC VOLUME FLOW METER, Journal of pharmacological and toxicological methods, 31(3), 1994, pp. 153-160
INHIBITION OF NITRIC-OXIDE SYNTHASE PREVENTS MYOCARDIAL PROTECTION BYRAMIPRILAT
Authors: HARTMAN JC KURC GM HULLINGER TG WALL TM SHEEHY RM SHEBUSKI RJ
Citation: Jc. Hartman et al., INHIBITION OF NITRIC-OXIDE SYNTHASE PREVENTS MYOCARDIAL PROTECTION BYRAMIPRILAT, The Journal of pharmacology and experimental therapeutics, 270(3), 1994, pp. 1071-1076
REDUCTION OF MYOCARDIAL INFARCT SIZE IN RABBITS BY RAMIPRILAT - REVERSAL BY THE BRADYKININ ANTAGONIST HOE-140
Authors: HARTMAN JC WALL TM HULLINGER TG SHEBUSKI RJ
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE IN RABBITS BY RAMIPRILAT - REVERSAL BY THE BRADYKININ ANTAGONIST HOE-140, Journal of cardiovascular pharmacology, 21(6), 1993, pp. 996-1003
REDUCTION OF MYOCARDIAL INFARCT SIZE BY RAMIPRILAT IS INDEPENDENT OF ANGIOTENSIN-II SYNTHESIS INHIBITION
Authors: HARTMAN JC HULLINGER TG WALL TM SHEBUSKI RJ
Citation: Jc. Hartman et al., REDUCTION OF MYOCARDIAL INFARCT SIZE BY RAMIPRILAT IS INDEPENDENT OF ANGIOTENSIN-II SYNTHESIS INHIBITION, European journal of pharmacology, 234(2-3), 1993, pp. 229-236
ROLE OF NITRIC-OXIDE IN THE MYOCARDIAL PROTECTIVE ACTION OF RAMIPRILAT
Authors: HARTMAN JC KURC GM HULLINGER TG SHEBUSKI RJ
Citation: Jc. Hartman et al., ROLE OF NITRIC-OXIDE IN THE MYOCARDIAL PROTECTIVE ACTION OF RAMIPRILAT, Circulation, 88(4), 1993, pp. 330-330
Risultati: 1-10 |